Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.060
-0.090 (-4.19%)
Aug 15, 2025, 10:43 AM - Market open
CNTB Revenue
Connect Biopharma Holdings had revenue of $48.00K in the quarter ending June 30, 2025, a decrease of -99.80%. This brings the company's revenue in the last twelve months to $1.97M, down -91.85% year-over-year. In the year 2024, Connect Biopharma Holdings had annual revenue of $26.03M.
Revenue (ttm)
$1.97M
Revenue Growth
-91.85%
P/S Ratio
60.57
Revenue / Employee
$31,694
Employees
62
Market Cap
114.79M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 26.03M | - | - |
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Jan 1, 2022 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CNTB News
- 1 day ago - Connect Biopharma Teams with Ickey Woods and the Jovante Woods Foundation to Expand Asthma Education Program Nationwide - GlobeNewsWire
- 2 days ago - Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 24 days ago - Connect Biopharma Appoints Industry Veteran Jim Schoeneck to its Board of Directors - GlobeNewsWire
- 25 days ago - Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq - GlobeNewsWire
- 4 weeks ago - Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference - GlobeNewsWire
- 4 weeks ago - Connect Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 2 months ago - Connect Biopharma Presents Data Supporting Rademikibart at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress - GlobeNewsWire
- 2 months ago - Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress - GlobeNewsWire